chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red rashes over my arms, in my elbows, in my face; red rashes on arms, face and elbows, and her arms and face were also itching badly; swollen and sore and it felt warm to the touch, but now it seems the swelling is down; swollen and sore and it felt warm to the touch, but now it seems the swelling is down; swollen and sore and it felt warm to the touch, but now it seems the swelling is down; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 17Aug2021 (Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on unspecified date as dose 1, single for covid-19 immunisation and experienced arm was just a little stiff. The patient got the vaccine and in Aug2021 was having these red rashes on arms, face and elbows, and her arms and face were also itching badly. She wanted to get an idea how long this rash will last. The arm was a little swollen and sore, and felt warm to the touch, but at the time of reporting it seemed that the swelling was down, arm was cool, but the rash. The outcome of feeling of warmth was recovered in Aug2021, outcome of swelling was recovering, and outcome of all other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling/redness/induration 12 x 6 cm at left thigh - PREVNAR site. No sig. pain, no fever; will treat with cephalexin course.
Pfizer vaccine vial stored in freezer past stability date of 11/23/2021 and administered to patient on 12/2/2021
Patient received Moderna COVID Vaccine. Minutes after receiving the vaccine, patient reported swelling in throat and a cough. Patient took an Epi-Pen, 50mg injectable diphenhydramine, and 20mg famotidine. EMS was activated. Upon arrival, EMS administered 125mg Solu-Medrol and 25mg additional diphenhydramine. Patient was taken to ED and observed for 2 hours. Labs were drawn, charted diagnosis was anaphylaxis.
I started getting symptoms of sore throat that was scratchy and fatigue. I tested negative on 5/5/2022. I took a second COVID-19 test the next morning and that was positive. Then I developed a fever of 101, exhaustion, cough, hoarse voice, nasal congestion, headaches that lasted for 3 weeks. Post COVID-19, I have experienced migraines, my POTS issues have elevated, and my menstrual cycle is abnormal and last longer than normal. And the premenstrual symptoms are more worse with acne, moodiness, and cramping. I still have exhaustion to this day.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 24-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    No concomitant product use was reported.  Reportedly, Patient received full dose.  Date the vial was initially stored in the refrigerator was 04-Jun-2022. Vial did not undergone any temperature excursions.  No treatment information was provided.
Fatigue, muscle aches. Fever of over 103F, resolved quickly after taking acetaminophen. All symptoms of adverse reaction gone within 72 hours.
Unbearable stiffness and joint pain, chills, fever, sweating, swollen and itchy hands, and tightness in chest. Joint pain lasted for 2 days, chest tightness lasted for 4 days, and itchy and swollen hands lasted for approximately a week.
about 9d after the vaccine, at the L deltoid directly surrounding the injection site pt developed a red itchy warm blotchy rash.
Pain (R) arm, down to 3rd finger, hurts to raise it - since her injection.
on 5/20/21 I noticed 3 yellow spots on my chest that look like bruises but didn't hurt to touch. Now on 5/24/21 I have another yellow spot right under my right eye and the 3 on my chest are still there. I dont technically now if it is the vaccine that caused this but it did happen right after i took it.
This case was reported by a consumer via call center representative and described the occurrence of pain in a 57-year-old female patient who received SHINGRIX. On 25th April 2018 12:30, the patient received the 1st dose of SHINGRIX. In April 2018, 13 hrs after receiving SHINGRIX, the patient experienced pain and chills. On 26th April 2018, the patient experienced faint. In April 2018, the outcome of the pain and chills were recovered/resolved. On an unknown date, the outcome of the faint was recovering/resolving. It was unknown if the reporter considered the pain, faint and chills to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. In afternoon, the patient received SHINGRIX. On 26th April 2018, around 1:30 am the patient woke up around with aches and chills. On 26th April 2018, in the afterjnoon 1 day after receiving SHINGRIX, the patient felt faint almost fainted. The patient had denied permission to contact their physician. The reporter refused to answer any additional questions.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Feb2021 at 10:00 as dose 1, single (Lot number: EN5318), in left arm, on 24Feb2021 at 10:00 as dose 2, single (Lot number: EN6203), in left arm, on 24Sep2021 at 14:00 as dose 3 (booster), single (Lot number: FE3592), in left arm and on 11May2022 at 14:00 as dose 4 (booster), single (Lot number: FP4554) at the age of 66 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing); "pre-diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Celebrex, reaction(s): "known allergies: Celebrex", notes: known allergies: Celebrex; Morphine, reaction(s): "known allergies: morphine", notes: known allergies: morphine; Codeine, reaction(s): "known allergies: codeine", notes: known allergies: codeine. The patient was not pregnant at the time of vaccination. Was the patient taking any other medications/products within 2 weeks of starting COVID-19 treatment was reported as no. Did the patient previously received a COVID-19 Vaccine was reported as yes. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Positive, notes: original positive test. Therapeutic measures were taken as a result of covid-19. It was reported that, rebound of COVID-19 with symptoms slightly worse than the original symptoms. Rebound was 8 days after original positive test. The device date was on 23Jul2022.  No follow-up attempts are possible. No further information is expected.
Left arm extremely swollen from shoulder to just past the elbow,  Bicep diameter in left arm 2 inches larger than the unaffected arm.  pain, redness, and hot to the touch. First noticed the morning of 9/11, has persisted and is still present at this current time 9/12 3:12 PM.
Received a questionable result from right breast on mammogram in January, had a ultrasound guided biopsy on 02/20/2023. Got results on 02/25/2023 was due ductal epithelial proliferation with papillary features. No atypia or malignancy ID'd. Consultation on 03/15/2023 and am getting a lumpectomy on 03/23/2023.
horrific arm pain from shoulder to elbow that last for approximately 48 hours; chills; respiratory allergic reaction - stuffy head, nose running  for 4 days; constant sneezing for  36 hours
Strong metallic taste; Ringing in the right ear/Primarily in right ear but noticeable in left as well; Pain up through jaw within 5 minutes of injection; Pain  into right ear within 5 minutes of injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 24Feb2021 at 14:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known drug allergy. The patient did not receive any other medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021 at 14:05, the patient experienced pain up through jaw and into right ear within 5 minutes of injection. On 24Feb2021 at 14:15, the patient experienced strong metallic taste and a ringing in the right ear, which was continued to get worse. Primarily the ringing in the right ear but noticeable in the left as well. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events pain up through jaw and into right ear within 5 minutes of injection, strong metallic taste and a ringing in the right ear, primarily in the right ear but noticeable in the left as well was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 17Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Red large rash on upper arm. Warm to the touch (slightly itchy). Has gotten larger and redder since first appearing day after vaccine (six days now)
(L) shoulder pain/+ROM; cortisone inject; Needs physical tx for adhesive capsulitis of shoulder.
Right hand, joints and knuckles get swollen; Right hand, joints and knuckles hurt; Vaccine caused headache for two days; Vaccine caused fever for two days; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Right hand, joints and knuckles get swollen), ARTHRALGIA (Right hand, joints and knuckles hurt), HEADACHE (Vaccine caused headache for two days) and PYREXIA (Vaccine caused fever for two days) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe rheumatoid arthritis).   On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Right hand, joints and knuckles get swollen), ARTHRALGIA (Right hand, joints and knuckles hurt), HEADACHE (Vaccine caused headache for two days) and PYREXIA (Vaccine caused fever for two days). At the time of the report, JOINT SWELLING (Right hand, joints and knuckles get swollen) and ARTHRALGIA (Right hand, joints and knuckles hurt) was resolving and HEADACHE (Vaccine caused headache for two days) and PYREXIA (Vaccine caused fever for two days) had resolved.            No concomitant medication was reported. No treatment medication was reported.  The reporter's causality for the events of right hand, joints and knuckles get swollen, right hand, joints and knuckles hurt, vaccine caused headache for two days and vaccine caused fever for two days was not provided for Humira.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Around 4:30 pm my son began seizuring. His face became very red, his eyes dialated, and his eyes dazed. He began looking up to the right and he would not look at me. His right fist was clenched and he went into a full seizure for 1 hour and was rushed to the ER. He was transported to another hospital where he under went many tests.
The morning of May 30th, experienced hives all over torso and legs, as well as swollen lips. As of this report (6/1/21), still dealing with bouts of on and off hives and alternating areas swelling in lips and eyes. Currently treating symptoms with Benadryl which is helping to moderate symptoms. However, symptoms are still present.
I received her first covid-19 moderna vaccine in the Left Deltoid on 24 dec 2020 with minimal side effects. I received my  second injection covid-19 Moderna vaccine in the Left Deltoid 21 Jan 2021 and within 1-2  hours started experiencing debilitating shoulder pain. I saw an orthopedic surgeon the next day on 22 Jan 2021 - Dr.  He felt the second injection had been in my Left subacromial bursa or Rotator cuff that I was experiencing SIRVA (shoulder injury related to vaccine injection). I was treated with a 5-day steroid taper and subsequent PT.  As of to date I still have pain, limited range of motion and am still going to PT.
COMPLAIMED OF FEELING HOT, STOMACH UPSET, BLURRY VISION, LIGHT HEADED, VS BP - 97/72 HR 81, OBSERVED 30 MINS, OFFERED WATER AND PATIENT CONSUMING, BP RECHECKED POST 30 MINS NOW 118/72. PATIENT STATES FEELING BETTER, AND NEEDS TO EAT.
7 days post injection I noticed a small raised spot near the injection site that was approximately the size of a quarter. (7am)  By 9am the spot was about the size of 2 quarters, red and hot to touch.   As the day progressed the spot began to get larger, swell, become very warm to touch and extremely itchy.  By 9pm it was swollen to the size of a softball.   The next morning (24 hours since first onset of reaction)  it had progressed larger and encompassed most of my upper arm.   Today is now 8 days post reaction (14 days post injection) and it is still slightly warm on the edges of where the reaction spread and slightly red and occasionally itchy.
No adverse event; Patient received the bivalent shot as their primary dose; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received the bivalent shot as their primary dose) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 052D22A) for COVID-19 prophylaxis.     It was reported that the patient had no allergies to medications, food and other products. The patient did not have any medical history of acute and chronic illnesses at the time of vaccination. The patient had never been diagnosed or tested positive with COVID-19. No other vaccines were given to the patient within 1 moth prior to Moderna COVID-19 vaccination.     On 07-Nov-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 07-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received the bivalent shot as their primary dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received the bivalent shot as their primary dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received the bivalent shot as their primary dose).    The patient was not taking any other medications. The patient's healthcare provider was aware of the incidents.  No treatment details was reported.
Information has been received from a consumer concerning her daughter who became autistic after receiving a dose of MMR II. Upon internal review, autism was determined to be an other important medical event. No further information is available.
Swelling at site about  3" circumference, hot to touch for a week,  itching at injection site for 2 weeks, slight fever,99.9,  on day after injection for couple of hours. Tylenol taken for injection site pain and low grade fever.
Chills 7 days after second dose; Followed by ringing/heartbeat sound in left ear which has persisted; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 29Apr2021 at 14:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfur and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 as a single dose for COVID-19 immunisation. On 06May2021 at 18:00, the patient experienced chills 7 days after second dose followed by ringing/heartbeat sound in left ear which had persisted. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills 7 days after second dose followed by ringing/heartbeat sound in left ear which had persisted, were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report received from a patient concerned a 30 year old female. The patient's weight was 129 pounds, and height was 62 inches. The patient's past medical history included: Covid-19, and Covid-19 (omicron), and other pre-existing medical conditions included: The patient denied taking any medications regularly (except for vitamins and supplements like biotin for her hair for the past few years) or suffering from any other illness. She was generally super healthy. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855190, expiry: 27-APR-2022) dose was not reported, administered on 07-MAR-2022 for prophylactic vaccination. No concomitant medications were reported. On MAR-2022, the patient experienced not able to eat anything, very slight exertion like walking resulted in heavy breathing, body felt like intoxicated by vaccine/ felt like alcoholic drink, felt like exercising heavily which resulted staying in bed, dehydration, and she felt tired and entire time sick. On 07-MAR-2022, the patient experienced body aches, and chills. On 11-MAR-2022, the patient experienced very severe diarrhea. On 12-MAR-2022, the patient experienced super sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, super sick, not able to eat anything, very slight exertion like walking resulted in heavy breathing, body felt like intoxicated by vaccine/ felt like alcoholic drink, chills, and very severe diarrhea on 14-MAR-2022, was recovering from she felt tired and entire time sick, and felt like exercising heavily which resulted staying in bed, and had not recovered from dehydration. This report was non-serious.
w/in 24hr pf vax pt had pain, redness, swelling @ inj site;swelling & redness still visable on 16OCT96;pt also had fatigue & myalgia;
Received Hepatitis B vaccine #1 on 11/13/2006 around 4:15 pm. Mom called AM of 11/14/2006. Reports patient began having problems breathing between 6 and 6:15 PM on 11/13/2006. Returned home around 6:30 PM. Had difficulty breathing and a cough. Patient's mom called a nurse friend of hers and she was instructed to give benadryl. Benadryl was given around 7 PM  and repeated around 8 PM as he was still having difficulties. Patient fell asleep around 8:30 PM. This AM, patient reported a sore throat, but was able to go to school. A physician was consulted who determined patient had an allergic reaction to Hepatitis B. Patient was given advair diskus.
temperature excursion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2), administration date 16Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (1st dose, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (2nd dose, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PRODUCT TEMPERATURE EXCURSION ISSUE (non-serious), outcome "unknown", described as "temperature excursion".  Additional information: CDC suggested he calls us. Wife and caller both had both doses of covid vaccine and the booster on 16Sep2021. About a week later pharmacist called and said the booster shot wife and caller had were in a temperature excursion and wondering if they were having any side effects. Caller said they both had same side effects after boosters as they did after both doses of covid vaccine. Wondering if we have any records on file of the booster they received. Also wants to know if they should be revaccinated. And if booster shot, they got was in a temperature excursion, is that ok. Relayed information and transferred. Will fax for AEs.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (24Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.